This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Chinese Academy of Sciences. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Ronggui Hu: Innovator in Autism Treatment
Introduction
Ronggui Hu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment and prevention of autism. His innovative work has led to the development of a unique patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Ronggui Hu holds a patent titled "Use of ALDH1A and agonist, catalyst and inhibitor thereof." This patent discloses the use of ALDH1A and an agonist, a catalyst, and an inhibitor thereof. Specifically, it details the application of ALDH1A or an agonist in the preparation of a pharmaceutical composition or formulation aimed at treating and preventing autism. This groundbreaking work highlights the potential for new therapeutic approaches in addressing this complex condition.
Career Highlights
Ronggui Hu is affiliated with the Chinese Academy of Sciences, where he conducts his research and development activities. His position at this esteemed institution allows him to collaborate with other leading scientists and contribute to significant advancements in medical research.
Collaborations
Ronggui Hu has worked alongside notable colleagues, including Zijian Hao and Xingxing Xu. Their collaborative efforts have further enriched the research environment and fostered innovation in their respective fields.
Conclusion
Ronggui Hu's contributions to the field of autism treatment through his patent and research at the Chinese Academy of Sciences exemplify the impact of innovative thinking in medicine. His work continues to inspire advancements that may lead to better outcomes for individuals affected by autism.